Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type |Pathology location|Pathology Description|
1005-30-1|n/a,n/a|Sequence:1, Age:84,Type:shamexposed,Quantity:0,Unit:unit code not relevant,Application:not applicable or not supplied, Remarks:n/a|523 (0 in ERA)|Rat|Rat CDF (F344) /CrlBR|Male|Young Adult|Lifespan and lung pathology|No information on individuals available for this study
1005-30-2|n/a,n/a|Sequence:1, Age:84,Type:shamexposed,Quantity:0,Unit:unit code not relevant,Application:not applicable or not supplied, Remarks:n/a|541 (0 in ERA)|Rat|Rat CDF (F344) /CrlBR|Female|Young Adult|Lifespan and lung pathology|No information on individuals available for this study
1005-30-3|n/a,n/a|Sequence:1, Age:84,Type:Ce-144 on FAS particles,Quantity:21,Unit:kilobecquerels initial or established lung burden,Application:Inhalation, Remarks:initial lung burden 21±7.6 kBq|520 (0 in ERA)|Rat|Rat CDF (F344) /CrlBR|Male|Young Adult|Lifespan and lung pathology|No information on individuals available for this study
1005-30-4|n/a,n/a|Sequence:1, Age:84,Type:Ce-144 on FAS particles,Quantity:16,Unit:kilobecquerels initial or established lung burden,Application:Inhalation, Remarks:initial lung burden 16±6 kBq|539 (0 in ERA)|Rat|Rat CDF (F344) /CrlBR|Female|Young Adult|Lifespan and lung pathology|No information on individuals available for this study
1005-30-5|n/a,n/a|Sequence:1, Age:84,Type:Ce-144 on FAS particles,Quantity:66,Unit:kilobecquerels initial or established lung burden,Application:Inhalation, Remarks:initial lung burden 66±24 kBq|122 (0 in ERA)|Rat|Rat CDF (F344) /CrlBR|Male|Young Adult|Lifespan and lung pathology|No information on individuals available for this study
1005-30-6|n/a,n/a|Sequence:1, Age:84,Type:Ce-144 on FAS particles,Quantity:55,Unit:kilobecquerels initial or established lung burden,Application:Inhalation, Remarks:initial lung burden 55±25 kBq|125 (0 in ERA)|Rat|Rat CDF (F344) /CrlBR|Female|Young Adult|Lifespan and lung pathology|No information on individuals available for this study
1005-30-7|n/a,n/a|Sequence:1, Age:84,Type:Ce-144 on FAS particles,Quantity:205,Unit:kilobecquerels initial or established lung burden,Application:Inhalation, Remarks:initial lung burden 205±64 kBq|193 (0 in ERA)|Rat|Rat CDF (F344) /CrlBR|Male|Young Adult|Lifespan and lung pathology|No information on individuals available for this study
1005-30-8|n/a,n/a|Sequence:1, Age:84,Type:Ce-144 on FAS particles,Quantity:156,Unit:kilobecquerels initial or established lung burden,Application:Inhalation, Remarks:initial lung burden 156±47 kBq|188 (0 in ERA)|Rat|Rat CDF (F344) /CrlBR|Female|Young Adult|Lifespan and lung pathology|No information on individuals available for this study
		
